Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)

Galderma

Status: Completed

Conditions: Rosacea

Treatments: Other: Mirvaso® / Onreltea TM

Study type: Observational

Funder types: Industry

Identifiers

NCT02637232

RD.03.SPR.104160

Details and patient eligibility

About

The aim of the study is to evaluate the level of satisfaction among patients to whom Mirvaso® / Onreltea TM (trade mark) is prescribed.

Enrollment: 301 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients to whom the physician has already decided to prescribe Mirvaso® /OnrelteaTM according to package insert

Trial design

301 participants in 1 patient group

Mirvaso® / Onreltea TM

Treatment:

Other: Mirvaso® / Onreltea TM